These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8066262)

  • 1. [Comparison of urokinase and tissue-type plasminogen activator in transcatheter arterial fibrinolysis].
    Vignali C; Cioni R; Mascalchi M; Russo R; Palla A; Lencioni R; Napoli V; Bartolozzi C
    Radiol Med; 1994; 88(1-2):93-9. PubMed ID: 8066262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
    Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
    Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
    Ouriel K; Kandarpa K
    J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion.
    Shortell CK; Queiroz R; Johansson M; Waldman D; Illig KA; Ouriel K; Green RM
    J Vasc Surg; 2001 Nov; 34(5):854-9. PubMed ID: 11700486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolysis-block technique--a new local form of treatment of distal venous and arterial occlusions of the leg].
    Heimig T; Martin M
    Vasa; 1992; 21(3):289-93. PubMed ID: 1529634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.
    Semba CP; Bakal CW; Calis KA; Grubbs GE; Hunter DW; Matalon TA; Murphy TP; Stump DC; Thomas S; Warner DL
    J Vasc Interv Radiol; 2000 Mar; 11(3):279-87. PubMed ID: 10735420
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions.
    Schweizer J; Altmann E; Stösslein F; Florek HJ; Kaulen R
    Eur J Radiol; 1996 May; 22(2):129-32. PubMed ID: 8793432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I; Kessel DO; Berridge DC
    Cochrane Database Syst Rev; 2010 Mar; (3):CD001099. PubMed ID: 20238313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
    Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
    Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
    Ouriel K; Kandarpa K; Schuerr DM; Hultquist M; Hodkinson G; Wallin B
    J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy of acute peripheral arterial occlusions of limb arteries].
    Bucek J; Staffa R; Vojtísek B
    Rozhl Chir; 2011 Sep; 90(9):512-6. PubMed ID: 22320115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous recanalization of iliac artery occlusions: results of a prospective study.
    Blum U; Gabelmann A; Redecker M; Nöldge G; Dornberg W; Grosser G; Heiss W; Langer M
    Radiology; 1993 Nov; 189(2):536-40. PubMed ID: 8210387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
    Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
    J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.
    Dawson KJ; Hamilton G
    Radiology; 1991 Jan; 178(1):283-4. PubMed ID: 1898537
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial.
    Mahler F; Schneider E; Hess H;
    J Endovasc Ther; 2001 Dec; 8(6):638-47. PubMed ID: 11797982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor.
    Eckert B; Kucinski T; Pfeiffer G; Groden C; Zeumer H
    Cerebrovasc Dis; 2002; 14(1):42-50. PubMed ID: 12097850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolysis therapy in peripheral arterial occlusions in combination with angioplasty procedures].
    Hagg NB
    Vasa Suppl; 1991; 33():129-30. PubMed ID: 1838620
    [No Abstract]   [Full Text] [Related]  

  • 20. [Local lysis therapy in acute arterial thrombosis].
    Roth FJ; Rieser R; Scheffler A
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():427-34. PubMed ID: 1983584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.